|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 38/19 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/02 | (2006.01) |
| (11) | Number of the document | 2768525 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12842352.2 |
| Date of filing the European patent application | 2012-10-18 | |
| (97) | Date of publication of the European application | 2014-08-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation | 2019-09-25 |
| (86) | Number | PCT/US2012/060739 |
| Date | 2012-10-18 |
| (87) | Number | WO 2013/059406 |
| Date | 2013-04-25 |
| (30) | Number | Date | Country code |
| 201161548518 P | 2011-10-18 | US | |
| 201261669480 P | 2012-07-09 | US |
| (72) |
MANNING, Mark, US
MURPHY, Brian, US
|
| (73) |
Coherus Biosciences, Inc.,
333 Twin Dolphin Drive Suite 600, Redwood City, CA 94065,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Etanercepto kompozicijos, stabilizuotos magnio jonais |
| ETANERCEPT FORMULATIONS STABILIZED WITH MAGNESIUM IONS |
| Payment date | Validity (years) | Amount | |
| 2022-10-17 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-10-18 |